XPeng stock today: XPEV slides in premarket as China trade-in subsidies and new G7 REEV grab attention

XPeng stock today: XPEV slides in premarket as China trade-in subsidies and new G7 REEV grab attention

NEW YORK, December 31, 2025, 06:15 ET — Premarket

  • XPeng shares fell 4.2% in premarket trading after a 3.8% gain in the prior session
  • China earmarked 62.5 billion yuan for 2026 trade-in subsidies, including incentives for new-energy vehicles
  • XPeng’s CEO outlined plans for a new range-extended G7 variant, with a 2026 debut targeted

XPeng Inc shares fell 4.2% to $20.38 in premarket trading on Wednesday, after ending the previous session up 3.8% at $21.28. Premarket volume was about 73,000 shares as of 5:59 a.m. ET. 1

The early drop lands as investors balance year-end positioning with fresh signals from Beijing on consumer support. For Chinese new-energy vehicles — a category that includes battery-electric cars and plug-in hybrids — policy changes can quickly reshape demand expectations.

China has earmarked 62.5 billion yuan ($8.94 billion) from special treasury bonds for a consumer goods trade-in scheme in 2026, state news agency Xinhua reported. Vehicle incentives include subsidies of up to 20,000 yuan for scrapping old cars and buying new-energy vehicles. 2

China’s President Xi Jinping said policymakers would adopt more proactive macro policies in 2026, reinforcing expectations that officials will keep leaning on consumption and investment to stabilise growth. 3

On the company front, XPeng Chairman and CEO He Xiaopeng revealed a G7 Super range-extended electric vehicle, or REEV — a battery car that carries a small gasoline engine to generate electricity when needed. He said the model offers “a combined driving range of up to 1,704 kilometers,” and is slated for a formal debut in the first quarter of 2026, according to Gasgoo. 4

Range-extended models have become a hot battleground in China as automakers try to ease range concerns without relying entirely on public charging. Li Auto has built its business around the format, while several rivals have moved to add similar options.

XPeng shares rallied in Tuesday’s regular session as traders reacted to the 2026 subsidy funding headlines, but the pullback in extended-hours trade suggests investors are still quick to take profits. Year-end liquidity can magnify moves, especially in U.S.-listed China ADRs.

The next near-term catalyst is the round of early-January delivery updates from Chinese EV makers, which often set the tone for sentiment at the start of the month. Investors will also be watching for any additional detail on how 2026 trade-in funding is distributed across vehicle types and regions.

Pricing for XPeng’s new G7 REEV variant has not been announced, leaving analysts to rely on assumptions for 2026 demand and margins. The sector has been under pressure from price competition, making any signal on pricing power a key swing factor.

Technically, Barchart data put support near $20.89 and $20.50, with resistance around $21.82 and $22.35. A sustained break below support would leave the stock retracing more of Tuesday’s advance, while a move back above $22 would refocus traders on late-December highs. 5

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
SoundHound AI (SOUN) stock slips in premarket after insider sales disclosures
Previous Story

SoundHound AI (SOUN) stock slips in premarket after insider sales disclosures

Rivian stock slips again in premarket after CEO share-sale disclosure, with Tesla deliveries next
Next Story

Rivian stock slips again in premarket after CEO share-sale disclosure, with Tesla deliveries next

Go toTop